Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=95 Randomized Treatment

Treatment Engagement With Technology-assisted Treatment

Alcoholism · Substance-related Disorders · Mentally Ill Chemical Abuse · Educational Technology

Bottom Line

View on ClinicalTrials.gov: NCT02674477 ↗
Enrolled (actual)
95
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Acceptability of Treatment Based on Survey Questionnaire Completed by Participants — 8.78; 8.23 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Therapeutic Education System (TES) (Device); Treatment as Usual (TAU) (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Johns Hopkins University
Primary completion
Jun 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Acceptability of Treatment Based on Survey Questionnaire Completed by Participants		 8.78; 8.23 —
SECONDARY
Number of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge		 23; 19 —
SECONDARY
Number of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge		 18; 22 —

Summary

This research is being done to study whether using an Internet-based program, called the Therapeutic Education System (TES), would be helpful for the treatment of substance use and other psychiatric problems.

Eligibility Criteria

Inclusion Criteria

  • diagnosis of drug or alcohol problem, plus another psychiatric problem, such as depression or anxiety
  • drug or alcohol use in the last 30 days
  • proficiency in English
  • able to consent to study
  • willing to engage in outpatient treatment
  • willing to allow study team to contact outpatient providers

Exclusion Criteria

  • psychotic symptoms, such as hearing voices
  • involuntary admission
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02674477). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search